IS NEOADJUVANT CHEMORADIATION A RISK FACTOR FOR 90-DAY MORTALITY AFTER PNEUMONECTOMY FOR LUNG CANCER IN THE CURRENT ERA?

被引:0
|
作者
Oxenberg, Jacqueline [1 ]
Scott, Walter J. [2 ]
Li, Tianyu [2 ]
Ross, Eric [2 ]
Lebenthal, Avi [3 ]
Shah, Prashant [2 ]
Turaka, Aruna [2 ]
Borghaei, Hossein [2 ]
King, Earl [2 ]
Goldberg, Melvyn [2 ]
Feigenberg, Steven [4 ]
Movsas, Benjamin [5 ]
Langer, Corey J. [6 ]
机构
[1] Philadelphia Coll Osteopat Med, Philadelphia, PA USA
[2] Fox Chase Canc Ctr, Philadelphia, PA USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Univ Maryland, Sch Med, College Pk, MD 20742 USA
[5] Henry Ford Hosp, Detroit, MI USA
[6] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S493 / S494
页数:2
相关论文
共 50 条
  • [21] Age-Associated Risk of 90-Day Postoperative Mortality After Cytoreductive Surgery for Advanced Ovarian Cancer
    Kumar, Seema
    Hossain, Jobayer
    Inge, Thomas
    Balagopal, P. Babu
    JAMA SURGERY, 2019, 154 (07) : 669 - 671
  • [22] Prediction of 90-day mortality risk after unplanned emergency department visits of advanced stage cancer patients
    Jeryczynski, Georg
    Krall, Christoph
    Pasalic, Sabina
    Huber, Dominikus
    Cacioppo, Filippo
    Bartsch, Rupert
    Fuereder, Thorsten
    Laggner, Anton
    Preusser, Matthias
    Minichsdorfer, Christoph
    SUPPORTIVE CARE IN CANCER, 2024, 32 (11)
  • [23] Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer (vol 156, pg 836, 2021)
    D'Journo, X. B.
    Boulate, D.
    Fourdrain, A.
    JAMA SURGERY, 2021, 156 (09) : 894 - 894
  • [24] Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
    Jason W. Denbo
    Morgan L. Bruno
    Jordan M. Cloyd
    Laura Prakash
    Jeffrey E. Lee
    Michael Kim
    Christopher H. Crane
    Eugene J. Koay
    Sunil Krishnan
    Prajnan Das
    Bruce D. Minsky
    Gauri Varadhachary
    Rachna Shroff
    Robert Wolff
    Milind Javle
    Michael J. Overman
    David Fogelman
    Thomas A. Aloia
    Jean-Nicolas Vauthey
    Jason B. Fleming
    Matthew H. G. Katz
    Journal of Gastrointestinal Surgery, 2016, 20 : 1975 - 1985
  • [25] Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
    Denbo, Jason W.
    Bruno, Morgan L.
    Cloyd, Jordan M.
    Prakash, Laura
    Lee, Jeffrey E.
    Kim, Michael
    Crane, Christopher H.
    Koay, Eugene J.
    Krishnan, Sunil
    Das, Prajnan
    Minsky, Bruce D.
    Varadhachary, Gauri
    Shroff, Rachna
    Wolff, Robert
    Javle, Milind
    Overman, Michael J.
    Fogelman, David
    Aloia, Thomas A.
    Vauthey, Jean-Nicolas
    Fleming, Jason B.
    Katz, Matthew H. G.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (12) : 1975 - 1985
  • [26] An Histological Appraisal of 90-day Mortality Risk in Alcoholic Hepatitis
    Andrade, Patricia
    Silva, Marco
    Rodrigues, Susana
    Lopes, Susana
    Lopes, Joanne
    Macedo, Guilherme
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S880 - S880
  • [27] 90-day mortality after radical radiotherapy and 30-day mortality after high dose palliative radiotherapy in lung cancer patients at the University Hospitals Birmingham
    Myint, Y. Maung Maung
    Watkins, S.
    Howard, H.
    Jackson, T.
    LUNG CANCER, 2017, 103 : S58 - S58
  • [28] Neoadjuvant chemotherapy is a risk factor for bronchopleural fistula after pneumonectomy for non-small cell lung cancer
    Samancilar, Ozgur
    Kaya, Seyda Ors
    Usluer, Ozan
    Ozturk, Taner
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2014, 11 (01): : 40 - 43
  • [29] Analysis of 30-And 90-day Mortality after Lung SBRT as an Indicator for Its Appropriateness
    Videtic, G.
    Reddy, C.
    Stephans, K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S536 - S536
  • [30] Analysis of 30-and 90-day mortality after lung SBRT as an indicator for its appropriateness
    Videtic, Gregory
    Reddy, Chandana
    Stephans, Kevin
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1577 - S1578